Skip to content

Impact of occult-bacterial translocation on postoperative infectious complications in patients with malignant obstructive jaundice

Impact of occult-bacterial translocation on postoperative infectious complications in patients with malignant obstructive jaundice

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078626
Enrollment
Unknown
Registered
2023-12-14
Start date
2023-05-15
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant obstructive jaundice

Interventions

OBT group:None
Non-OBT group:None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1:No infection-related clinical symptoms and signs were found in the patient: body temperature monitoring was < 37.3C from admission to pre-operation, WBC count was 4~10×10^9/ L, neutrophil ratio was normal, mental consciousness was normal, and PCT was normal. 2:the patients had clinical manifestations of obstructive jaundice, such as yellow staining of skin and mucosa, yellow staining of sclera, skin itching, bradycardia, dark urine, lighter feces or white clay. 3:Serum total bilirubin increased, mainly direct bilirubin, alanine transaminase, aspartate aminotransferase, alkaline phosphatase and ?-glutamyltransferase increased or normal, urinary bilirubin increased, fecal bilirubin decreased or disappeared. 4:Imaging examination, including ultrasound, CT or MRCP, showing obstructive bile duct dilatation caused by malignant hepatobiliary and pancreatic diseases. 5:The competent surgeon assessed the need for surgery to relieve the obstruction.

Exclusion criteria

Exclusion criteria: 1:Age is <18 years old 2:Those who cannot tolerate surgery 3:Preoperative chemotherapy and / or radiotherapy, or immune drugs, or targeted drug therapy 4:There is a history of other abdominal operations within half a year.

Design outcomes

Primary

MeasureTime frame
white blood cell;neutrophilic granulocyte percentage;blood platelet count;procalcitonin;c reactive protein;interleukin-6;T lymphocyte subsets;immune globulin;complement in blood serum;Incidence of postoperative infectious complications (pneumonia, cholangitis, gastroenteritis, surgical site infection);

Secondary

MeasureTime frame
Clavien-Dindo complication rating;Incidence of postoperative sepsis;average stay;90-day postoperative mortality;

Countries

China

Contacts

Public ContactZhang Wen

The First Affiliated Hospital of Guangxi Medical University

wenzgxmu@163.com+86 138 7810 8107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026